跳至主要内容
临床试验/PACTR201907764652028
PACTR201907764652028已完成4 期

Cardioprotective effect of propofol in cardioplegia compared to systemic propofol in heart valves surgery; a randomized controlled trial

Tanta University Hospital0 个研究点目标入组 150 人开始时间: 2018年11月22日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
All

入选标准

  • The study will include all patients subjected to valve replacement or repair due to rheumatic affection.
  • Those patients will be categorized into three groups:
  • *Group 1(patients with propofol in the cardioplegia and placebo injection in the aortic line).
  • *Group 2(patients with propofol injection in the aortic line before and after the aortic cross clamp and placebo injection in the cardioplegia).
  • *Group 3(patients with placebo injection either in the cardioplegia and aortic line).

排除标准

  • Patients less than 18 years old and more than 70 years old.
  • Patients with coronary artery disease.
  • Patients subjected to complex aortic surgery(arch or root surgery).
  • Patients with allergy to propofol.
  • Emergency cardiac surgery.
  • Redo cardiac surgery.
  • Minimal invasive cardiac surgery.
  • Non-rheumatic valve pathology.
  • Patients with end stage renal failure.

研究者

发起方
Tanta University Hospital

相似试验